TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 11/03/25

Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the Only Approved for Use Regardless of Prior Disease Exposure Takeda is Expanding Global Access to QDENGA in Partnership ...

2025-10-31 10:39:51 ET Yes, as always, I'll start with a quote , but today it's from "A Farewell to Arms," by my favorite writer, Ernest Hemingway.... Read the full article on Seeking Alpha For further details see: AbbVie: Why Q3 Confirms Its Immunology Dominance

2025-10-31 04:59:14 ET Takeda Pharmaceutical Company Limited (TAK) Q2 FY2025 Earnings Call October 30, 2025 6:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q2 FY2025 Earnings Call Transcript

2025-10-30 16:16:24 ET Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call October 30, 2025 6:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call Transcript

California Water Service Group (CWT) is expected to report $1.2 for Q3 2025 Gilead Sciences Inc. (GILD) is expected to report $2.15 for Q3 2025 Schneider National Inc. (SNDR) is expected to report $0.21 for Q3 2025 Fidus Investment Corporation (FDUS) is expected to report $0.5 for Q3 ...

2025-10-30 04:10:10 ET More on Europe EUR/USD Price Holds As ECB Comments And Trade Optimism Lift Sentiment EUR/USD Price Forecast 2026: Dollar Strength Keeps Euro Under Pressure A EUR/USD Guide On How Long-Term Trends Reverse Europe indexes almost flat await...

2025-10-30 03:17:02 ET More on Takeda Pharmaceutical Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules Transcript Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic C...

First Half Revenue Declined 3.9% at Constant Exchange Rate (CER), -6.9% at Actual Exchange Rates (AER), Impacted by Generic Erosion of VYVANSE® and FX Headwind Core Operating Profit Declined 8.8% at CER in the First Half, Reflecting Revenue Performance and Product...

2025-10-29 18:00:56 ET Major earnings expected before the bell on Thursday include: Altria Group ( MO ) Merck & Co. ( MRK ) Enterprise Products Partners L.P. ( EPD ) Bristol-Myers Squibb Company ( BMY ) Mastercard Incorporated ( MA ) Rea...

2025-10-27 14:56:47 ET Read the full article on Seeking Alpha For further details see: Harmony Biosciences: Performing Commercially But Competition Afoot